/
PALI
$2.15+$0.19 (+9.69%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$341.6M
174M shares
52-week range
$0.53 – $2.86
70% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
Change$-1827.85
Palisade Bio, Inc. Common Stock
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
www.palisadebio.com- Employees
- 14
- IPO / List date
- Apr 28, 2021
- HQ
- CARLSBAD, CA
Held by traders on TradeandTell
No one on the platform currently holds PALI.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,454,400 | $2.5M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-04-08 | 1-for-15reverse |
| 2022-11-16 | 1-for-50reverse |
| 2019-07-18 | 1-for-20reverse |
| 2017-01-09 | 1-for-13reverse |
Recent trades on TradeandTell
No one on the platform has traded PALI yet.
